Skip to main content
. 2017 Jan 27;8(9):15393–15398. doi: 10.18632/oncotarget.14871

Table 1. The correlation between expression of CASC9 mRNA and clinical characteristics in 89 gastric cancer specimens.

Factors n x ± s F P
size (cm) < 6.0 41 2.880 ± 1.643
≥ 6.0 48 3.762 ± 1.966 4.916 0.029*
site lower 48 3.656 ± 2.042
middle 19 3.286 ± 1.824
upper 16 2.129 ± 0.956 3.101 0.031*
total 6 4.260 ± 0.784
Borrmann type 1/2 15 2.063 ± 0.789 7.320 0.008*
3/4 74 3.584 ± 1.914
Depth of invassion T2/3 25 2.612 ± 1.270 6.154 0.015*
T4 64 3.684 ± 1.995
infiltrating pattern INFα/β 34 2.306 ± 1.093 21.579 < 0.001*
INFγ 55 4.036 ± 1.956
differentiation Well/moderate 31 2.114 ± 1.147 23.782 < 0.001*
poor 58 3.979 ± 1.858
Lymphatic/venous invasion 54 3.362 ± 2.208 0.004 0.947
+ 35 3.389 ± 1.179
TNM Node classification (7th) N0 (0) 27 1.916 ± 1.066 21.219 < 0.001*
N1(1–2) 23 3.258 ± 1.324
N2 (3–6) 21 3.670 ± 1.524
N3 (≥ 7) 18 5.359 ± 1.864

Note: *indicates the difference is significant.